-
Over 50 million doses of Sputnik V to be made in India
Besides five drug companies that had tie-ups, Russian firms says they are looking for a couple of more firms for the possible production pacts
-
Modi calls for global efforts to deal with coronavirus crisis
Prime Minister said India tried to protect its 1.3 billion nationals from COVID-19, and, at the same time, tried to support pandemic response efforts
-
COVID-19 second wave worrying; some states need to ramp up RT-PCR tests: Centre
Union Health Secretary Rajesh Bhushan said the Centre is continuously trying to help states and union territories in tackling the pandemic in a more e
-
Looking for winners? These sectors may benefit from Covid second wave
Retail participation in the equity market has gone up tremendously. FY21 saw almost 1 crore new Demat accounts being opened, which was the highest in
-
Defying gravity? These BSE stocks hit upper circuit even as Sensex tanked 1,708 points
As many as 193 stocks on the BSE hit upper circuit despite weakness in the market
-
Covid second wave: How stock market investors are reacting to rising infections
Fitch Ratings has said the second wave of infections poses increased risks for India’s fragile economic recovery and its banks
-
Stock market crash: Why Sensex tumbled over 1,400 points today
The 30-share BSE index traded 1,427 points lower at 48,164.32, while the broader NSE Nifty plunged 432 points to 14,402.95
-
Why Jubilant Pharmova shares rally over 6% in a weak market
The scrip traded 6.25% higher at Rs 782.50 at around 10 am (IST). On the other hand, the benchmark BSE Sensex was down 1,175 points, or 2.37%, at 48,4
-
Investors lose Rs 8,68,000 crore as rising Covid-19 cases spook D-Street sentiment
The benchmark BSE Sensex traded 1,155 points, or 2.33%, down at 48,436.
-
Almost 71% Covid-19 cases from Maharashtra, UP, Karnataka, Chhattisgarh, Kerala
India's total active caseload has increased to 11,08,087 and it now comprises 8.29% of the country's total infections
